3SBio to go private in buy-out worth $344mm; gets higher offer from CEO; Decade ups offer
Executive Summary
Leading public Chinese biotech 3SBio Inc. has agreed to be acquired by Decade Sunshine Ltd. for $15.40 per ADS (a 36% premium), valuing the deal at $344mm.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Vaccines
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
- Includes Contract
- Payment Includes Cash for Equity
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice